Theseus Pharmaceuticals Statistics Share Statistics Theseus Pharmaceuticals has 44.65M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 44.65M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 14.26M Failed to Deliver (FTD) Shares 1,504,081 FTD / Avg. Volume 177.03%
Short Selling Information The latest short interest is 401.68K, so 0.9% of the outstanding
shares have been sold short.
Short Interest 401.68K Short % of Shares Out 0.9% Short % of Float 1.9% Short Ratio (days to cover) 1.08
Valuation Ratios The PE ratio is -4.07 and the forward
PE ratio is null.
Theseus Pharmaceuticals's PEG ratio is
-0.07.
PE Ratio -4.07 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.92 P/FCF Ratio -5.74 PEG Ratio -0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Theseus Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 17.79,
with a Debt / Equity ratio of 0.02.
Current Ratio 17.79 Quick Ratio 17.79 Debt / Equity 0.02 Debt / EBITDA -0.07 Debt / FCF -0.12 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.24M Employee Count 38 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -3.53M Effective Tax Rate 6.97%
Stock Price Statistics The stock price has increased by 0.25% in the
last 52 weeks. The beta is 3.98, so Theseus Pharmaceuticals's
price volatility has been higher than the market average.
Beta 3.98 52-Week Price Change 0.25% 50-Day Moving Average 3.99 200-Day Moving Average 4.75 Relative Strength Index (RSI) 59.85 Average Volume (20 Days) 849,600
Income Statement
Revenue n/a Gross Profit -438K Operating Income -54.09M Net Income -47.08M EBITDA -54.09M EBIT -54.14M Earnings Per Share (EPS) -1.22
Full Income Statement Balance Sheet The company has 94.61M in cash and 3.98M in
debt, giving a net cash position of 90.63M.
Cash & Cash Equivalents 94.61M Total Debt 3.98M Net Cash 90.63M Retained Earnings -112.19M Total Assets 234.63M Working Capital 202.58M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -32.95M
and capital expenditures -455K, giving a free cash flow of -33.4M.
Operating Cash Flow -32.95M Capital Expenditures -455K Free Cash Flow -33.4M FCF Per Share -0.87
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
